Poster Abstract Session:
130. Adult and Pediatric Influenza Vaccine
Friday, October 5, 2018: 12:30 PM-1:45 PM
Room: S Poster Hall

Tracks: Adult ID, Pediatric ID

Safety of Guidelines Recommending LAIV for Routine Use in Children and Adolescents with Asthma
James Nordin, MD, MPH; Gabriela Vazquez-Benitez, PhD; Avalow Olsen, BS; Leslie Kuckler, MPH; Elyse Kharbanda, MD, MPH
  • LAIV Asthma.pdf (228.2 kB)
  • 986
    Evaluation of Moderate-to-Severe Influenza Disease in Children 6 months to 8 years of age in Colorado
    Suchitra Rao, MBBS; Molly Lamb, PhD; Angela Moss, MS; Emad Yanni, MD, MSC; Rafik Bekkat-Berkani, MD; Anne Schuind, MD; Bruce Innis, FIDSA; Jillian Cotter, MD; Rakesh Mistry, MD; Edwin J. Asturias, MD
    Repeated Exposure to an Adjuvanted Quadrivalent Subunit Influenza Virus Vaccine (aQIV): A Randomized, Observer Blind, Multicenter Study
    Wendy Daly, MD; Keith Ramsey, DO; Aino Forsten, MD; Esther Heijnen, MD, PhD; Brett Leav, MD; Janine Oberye, MSc; Bin Zhang, ScD; Filippo Pacciarini, PhD; Timo Vesikari, MD, PhD
    Effectiveness of Seasonal Influenza Vaccines Against Influenza A(H3N2) Illness Among Children Aged <18 Years, US Flu VE Network, 2010-2018
    Brendan L. Flannery, PhD; Jessie Chung, MPH; Michael L. Jackson, PhD, MPH; Lisa A. Jackson, MD, MPH, FIDSA; Arnold S. Monto, MD, FIDSA; Emily T. Martin, MPH, PhD; Edward Belongia, MD; Huong McLean, PhD, MPH; Richard K. Zimmerman, MD MPH, FIDSA; Mary Patricia Nowalk, PhD RD; Manjusha Gaglani, MBBS; Marie R. Griffin, MD, MPH; H. Keipp Talbot, MD, MPH; John J. Treanor, MD; Sarah Spencer, PhD; Alicia M. Fry, MD, MPH
    Clinical Effectiveness of High-Dose Trivalent versus Quadrivalent Influenza Vaccination among Veterans Health Administration Patients
    Yinong Young-Xu, ScD, MS, MA; Ellyn Russo, MS; Nabin Neupane, BS; Melissa Lewis, AD; Yuliya Halchenko, MA
    2016/2017 Influenza Burden of Disease and End-of-Season Influenza Vaccine Effectiveness (VE) Estimates for Preventing Influenza-Related Hospitalization Among Canadian Adults: An Analysis from the Canadian Immunization Research Network (CIRN) Serious Outcomes Surveillance (SOS) Network
    Michaela Nichols, MSc; Melissa K Andrew, MD, PhD; Todd F Hatchette, MD FRCPC; Ardith Ambrose, RN; Guy Boivin, MD, MSc; May Elsherif, MD; Karen Green, MSc, RN; Jennie Johnstone, MD, PhD; Kevin Katz, MD, CM, MSc, FRCPC; Jason Leblanc, PhD; Mark Loeb, MD, MSc; Donna Mackinnon-Cameron, MMath; Anne Mccarthy, MD; Janet McElhaney, MD; Allison McGeer, MD, MSc; Andre Poirier, MD, MSc; Jeff Powis, MD, MSc, FRCPC; David Richardson, MD; Makeda Semret, MD; Daniel Smyth, MD, FRCPC; Sylvie Trottier, MD, PhD; Louis Valiquette, MD, MSc, FRCPC; Duncan Webster, MD; Lingyun Ye, MSc; Shelly A McNeil, MD, FIDSA
    Combining Key Residues of the Russian and U.S. Live-Attenuated Influenza Viruses for a More Attenuated Virus.
    Andrew Smith, M.D./Ph.D. Candidate; Laura Rodriguez-Garcia, Ph.D.; Maya El Ghouayel, M.H.S., M.D. Candidate; Luis Martinez-Sobrido, Ph.D.; Stephen Dewhurst, Ph.D.
  • IDSA Conference Poster.pdf (385.0 kB)
  • 994
    AS03-Adjuvanted H5N1 Avian Influenza Vaccine Modulates Early Innate Immune Signatures in Peripheral Blood Mononuclear Cells
    Leigh Howard, MD, MPH; Johannes Goll, M.S.; Travis Jensen, B.S.; Heather Hill, MS; Casey Gelber, MS; C. Buddy Creech, MD, MPH, FPIDS; Kathryn Edwards, MD, FIDSA
    Effectiveness of influenza vaccine for prevention of influenza-associated hospitalizations among high-risk adults in the U.S., 2015 – 2016
    Elif Alyanak, MPH; Manjusha Gaglani, MBBS; Emily T. Martin, MPH, PhD; Arnold S. Monto, MD, FIDSA; Don Middleton, MD; Fernanda P. Silveira, MD, MS; Richard Zimmerman, MD, MPH; H. Keipp Talbot, MD, MPH; Jill M. Ferdinands, PhD, MSc
    A cluster-randomized trial of adjuvanted trivalent influenza vaccine vs. standard dose in U.S. nursing homes
    Stefan Gravenstein, MD, MPH; H. Edward Davidson, PharmD, MPH; Kevin Mcconeghy, Pharm.D.; Lisa Han, MPH; David Canaday, MD; Elie Saade, MD, MPH; Rosa R. Baier, MPH; Vincent Mor, PhD
    Protection of unvaccinated individuals by influenza vaccine coverage of household contacts
    Ryan E. Malosh, PhD; Richard Evans, MS; Emily T. Martin, MPH, PhD; Joshua G. Petrie, PhD; Arnold S. Monto, MD, FIDSA

    CME Credits: Maximum of 0.00 hours of AMA PRA Category 1 Credit™

    Findings in the abstracts are embargoed until 12:01 a.m. PDT, Wednesday Oct. 3rd with the exception of research findings presented at the IDWeek press conferences.